NCT03293719

Brief Summary

Prospective Post-Market Clinical Follow up study according to MEDDEV 2.12/2 rev2 of the European Union. Patients receiving the primary knee implant BPK-S UC as primary implant in either variant ceramic or CoCr (metal) are eligible for the study and will be followed up for 5 years after implantation or until revision of the prosthesis, whichever occurs first. Demographic data will be collected together with data regarding safety and benefit at defined timepoints (preoperative, intraoperative and at 3 months, 1 year, 2 years and 5 years after implantation). Patients will be divided in 2 cohorts (ceramic and metal) and stratified by age.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2018

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 19, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 26, 2017

Completed
6 months until next milestone

Study Start

First participant enrolled

March 20, 2018

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 14, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 14, 2019

Completed
Last Updated

November 19, 2019

Status Verified

November 1, 2019

Enrollment Period

1.6 years

First QC Date

September 19, 2017

Last Update Submit

November 15, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Patient relevant benefit after 5 years

    improvement of KSS-Score by at least one category as compared to preoperative basic assessment

    5 years

Secondary Outcomes (7)

  • Patient relevant benefit as measured by American Knee Society Score

    3 months, 1, 2 and 5 years

  • Patient relevant benefit as measured by Knee Osteoarthritis Outcome Score

    3 months, 1, 2 and 5 years

  • Patient Quality of Life

    3 months, 1, 2 and 5 years

  • Implant Loosening Number

    3 months, 1, 2 and 5 years

  • Implant Loosening Reason

    3 months, 1, 2 and 5 years

  • +2 more secondary outcomes

Study Arms (2)

Ceramic

Patients receiving BPK-S Integration UC implant made from BIOLOX delta ceramic

Device: BPK-S Integration UC

CoCr

Patients receiving BPK-S Integration UC implant made from CoCr (metal)

Device: BPK-S Integration UC

Interventions

Primary Knee Endoprosthesis

CeramicCoCr

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing primary total knee endoprosthesis with BPK-S Integration of age 18 and older

You may qualify if:

  • Congenital or acquired knee joint defects/deformation
  • Defects or malfunction of the knee joint
  • Arthrosis (degenerative, rheumatic)
  • Post-traumatic arthritis
  • Symptomatic knee instability
  • Reconstruction of flexibility
  • Patients with metal hypersensitivity (ceramic tibia/femur)

You may not qualify if:

  • Illnesses which can be treated without using a knee joint implant.
  • Acute or chronic infections near the implantation
  • Systemic diseases and metabolic disorders
  • Serious osteoporosis
  • Serious damage to the bone structures that impedes stable implantation of the implant components
  • Diseases that impair bone growth, e.g. cancer, renal dialysis, osteopenia, etc.
  • Bone tumors in the area of the implant anchoring
  • Obesity or overweight of the patient
  • Overload of the knee implant to be expected
  • Abuse of medication, drug abuse, alcoholism or mental disease
  • Pregnancy
  • Lack of patient cooperation
  • Sensitivity to foreign matter in the implant materials
  • Patients under the age of 18
  • Patients participating in another trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SMZ Ost, Donauspital

Vienna, Upper Austria, 1220, Austria

Location

MeSH Terms

Conditions

OsteoarthritisOsteoarthritis, KneeJoint InstabilityArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Condition Hierarchy (Ancestors)

Connective Tissue DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Christian E. Berger, Prof.

    Sozialmedizinisches Zentrum Ost - Donauspital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 19, 2017

First Posted

September 26, 2017

Study Start

March 20, 2018

Primary Completion

October 14, 2019

Study Completion

October 14, 2019

Last Updated

November 19, 2019

Record last verified: 2019-11

Locations